Sign in

CIK 0001479419

  • Non-accelerated filer
  • Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
270604595
Phone
+1 781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 46 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-16 Rosen Howard B Director Grant or award · Stock Option (right to buy) +40,000 40,000
2022-06-16 PERRY GREGORY D Director Grant or award · Stock Option (right to buy) +40,000 40,000
2022-06-16 Paull Robert Bradley Director Grant or award · Stock Option (right to buy) +40,000 40,000
2022-06-16 KOVEN ANDREW I Director Grant or award · Stock Option (right to buy) +50,000 50,000
2022-05-26 RA CAPITAL MANAGEMENT, L.P. 10% owner Sale −1,005,686 $0.36 $366K 7,039,613
2022-05-25 RA CAPITAL MANAGEMENT, L.P. 10% owner Sale −1,434,509 $0.42 $602K 8,045,299
2022-05-24 RA CAPITAL MANAGEMENT, L.P. 10% owner Sale −144,805 $0.51 $74K 9,479,808
2022-05-23 RA CAPITAL MANAGEMENT, L.P. 10% owner Sale −1,250,000 $0.65 $813K 9,624,613
2022-02-15 Kharabi Darius CHIEF BUSINESS OFFICER Other disposition −9 15,430
2022-01-04 Reumuth Mary CHIEF FINANCIAL OFFICER Sale −2,850 $1.30 $4K 133,208
2022-01-04 Brazzell Romulus K Sale −3,504 $1.30 $5K 288,345
2022-01-04 Bazemore Todd Sale −3,454 $1.30 $4K 118,591
2022-01-04 Iwicki Mark T CHIEF EXECUTIVE OFFICER Sale −9,518 $1.30 $12K 259,158
2022-01-04 Trachtenberg Eric Sale −2,850 $1.30 $4K 113,816
2022-01-03 Reumuth Mary CHIEF FINANCIAL OFFICER Grant or award · Stock Option (right to buy) +153,000 153,000
2022-01-03 Brazzell Romulus K Grant or award · Stock Option (right to buy) +238,000 238,000
2022-01-03 Bazemore Todd Grant or award · Stock Option (right to buy) +238,000 238,000
2022-01-03 Iwicki Mark T CHIEF EXECUTIVE OFFICER Grant or award · Stock Option (right to buy) +775,000 775,000
2022-01-03 Trachtenberg Eric Grant or award · Stock Option (right to buy) +153,000 153,000
2021-11-15 Kharabi Darius CHIEF BUSINESS OFFICER Grant or award +295,657 295,657

Page 13 of 19 · 378 trades